Valneva inks $1.7B U.K. deal for COVID-19 vaccine; Regeneron’s REGN-COV2 joins Recovery trial Sep. 14, 2020 By Nuala Moran No Comments LONDON – The U.K. government has signed a €1.4 billion (US$1.7 billion) advance purchase agreement with French biotech Valneva SE, for the supply of up to 190 million doses of its attenuated COVID-19 vaccine, VLA-2001.Read More